Open access
Oct 2026
Current Understanding of the Molecular Mechanisms of Resistance to Targeted Anti-HER2 Breast Cancer Therapy
This lecture summarizes current evidence on the molecular and genetic mechanisms of resistance to HER2targeted breast cancer therapies and places particular emphasis on factors limiting the efficacy of antibody drug conjugates, which are currently a subject of active investigation.
O. Bragina, E. Y. Sitnikova, A. A. Nesynov et al.
· Bulletin of Siberian Medicin... · 0 citations